Crixus BH3 Acquisition (BHAC)
Crixus BH3 Acquisition Statistics
Share Statistics
Crixus BH3 Acquisition has 6.92M shares outstanding. The number of shares has increased by -14.05% in one year.
| Shares Outstanding | 6.92M |
| Shares Change (YoY) | -14.05% |
| Shares Change (QoQ) | -0.45% |
| Owned by Institutions (%) | 34.66% |
| Shares Floating | 911.77K |
| Failed to Deliver (FTD) Shares | 35 |
| FTD / Avg. Volume | 1.27% |
Short Selling Information
The latest short interest is 520, so 0.01% of the outstanding shares have been sold short.
| Short Interest | 520 |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 17.93 |
Valuation Ratios
The PE ratio is -3.58 and the forward PE ratio is null. Crixus BH3 Acquisition's PEG ratio is 0.01.
| PE Ratio | -3.58 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 3.41 |
| P/FCF Ratio | -15.45 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Crixus BH3 Acquisition.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | -0.17 |
| Debt / FCF | -0.78 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.76M |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 104.16K |
| Effective Tax Rate | -1.94% |
Stock Price Statistics
The stock price has increased by -2.75% in the last 52 weeks. The beta is 0.32, so Crixus BH3 Acquisition's price volatility has been higher than the market average.
| Beta | 0.32 |
| 52-Week Price Change | -2.75% |
| 50-Day Moving Average | 10.32 |
| 200-Day Moving Average | 10.54 |
| Relative Strength Index (RSI) | 82.54 |
| Average Volume (20 Days) | 2.75K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -5.56M |
| Net Income | -5.27M |
| EBITDA | -5.56M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -2.85 |
Balance Sheet
The company has 19.67K in cash and 959.84K in debt, giving a net cash position of -940.17K.
| Cash & Cash Equivalents | 19.67K |
| Total Debt | 959.84K |
| Net Cash | -940.17K |
| Retained Earnings | -7.73M |
| Total Assets | 13.76M |
| Working Capital | -8.05M |
Cash Flow
In the last 12 months, operating cash flow was -1.22M and capital expenditures 0, giving a free cash flow of -1.22M.
| Operating Cash Flow | -1.22M |
| Capital Expenditures | 0 |
| Free Cash Flow | -1.22M |
| FCF Per Share | -0.66 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BHAC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for BHAC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 2.41 |
| Piotroski F-Score | 2 |